IPO Boutique

Five Prime Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Five Prime Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Five Prime TherapeuticsFPRX -
NASDAQ
$12.00-$14.00 $13.00 $16.002.8 million9/18/2013
Jefferies, BMO Capital Markets, Wells Fargo Securities
Co-Manager(s):
Guggenheim Securities
Health Care
Filing(s):

Filed 2013-07-26
Terms Added 2013-09-04



Five Prime Therapeutics Quote & Chart - Click for current quote - FPRX

About Five Prime Therapeutics (adapted from Five Prime Therapeutics prospectus):
They are a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "FPRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved